InVivoSIM anti-human TNFalpha (Infliximab Biosimilar)
SIM0006
ApplicationsFunctional Assay, Flow Cytometry, Western Blot, ELISA, Neutralisation/Blocking
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoSIM anti-human TNFalpha (Infliximab Biosimilar)
- Delivery Days Customer7
- ApplicationsFunctional Assay, Flow Cytometry, Western Blot, ELISA, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDInfliximab
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHuman
- IsotypeIgG1
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Di Ianni A, Fraone T, Balestra P, et al. Assessing MAPPs assay as a tool to predict the immunogenicity potential of protein therapeutics. Life Sci Alliance. 2024,7(1). doi: 10.26508/lsa.202302095Read this paper
- Wang X, Su S, Zhu Y, et al. Metabolic Reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors. Nat Commun. 2023,14(1):5778. doi: 10.1038/s41467-023-41470-9Read this paper
- Zheng N, Fang J, Xue G, et al. Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance. Cancer Cell. 2022,40(9):973-985.e7. doi: 10.1016/j.ccell.2022.08.001Read this paper
Datasheet
Related products
Product group Antibodies
References
ApplicationsWestern Blot, Neutralisation/Blocking
- SizePrice
Product group Antibodies
References
ApplicationsWestern Blot, Neutralisation/Blocking
- SizePrice
Product group Antibodies
References
ApplicationsFunctional Assay, Flow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoHistoChemistry, Neutralisation/Blocking
- SizePrice